Advanced Blood Analysis Devices Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, End User, Functionality, Installation Type, Equipment, Solutions

Description

The global Advanced Blood Analysis Devices Market is projected to grow from $105.5 billion in 2025 to $205.6 billion by 2035, at a compound annual growth rate (CAGR) of 6.9%. The Advanced Blood Analysis Devices Market is driven by the need for faster diagnostic testing, increasing demand for high-accuracy blood analysis, and advances in automated and point-of-care laboratory technologies. According to the CDCs FY 2025 Division of Laboratory Sciences report, CDC laboratories developed a new analytical method that reduced a critical step in newborn screening for lysosomal storage disorders from 18 hours to 3 hours, enabling same-day analysis and reporting. Advances in automated hematology analyzers, mass spectrometry, molecular diagnostics, biosensors, and microfluidic platforms are improving the speed and range of blood testing. Integration of automation and digital data systems is also supporting standardized, high-throughput analysis.

The Type segment of the Advanced Blood Analysis Devices Market includes Benchtop Analyzers, Portable Analyzers, Handheld Analyzers, and Others. Benchtop Analyzers held the largest share in 2025, supported by their high analytical capacity, broader testing capabilities, and extensive use in hospitals and diagnostic laboratories for blood gas, electrolyte, hematology, coagulation, and other advanced analyses. Portable Analyzers are expected to be the fastest-growing segment during the forecast period, driven by increasing demand for point-of-care testing, decentralized diagnostics, faster clinical decision-making, and testing outside conventional laboratories. Handheld analyzers are also gaining adoption where compact size and rapid testing are important.

Market Segmentation
Type	Benchtop Analyzers, Portable Analyzers, Handheld Analyzers, Others
Product	Blood Gas Analyzers, Electrolyte Analyzers, Glucose Analyzers, Coagulation Analyzers, Hematology Analyzers, Immunoassay Analyzers, Others
Technology	Spectroscopy, Flow Cytometry, Chromatography, Electrophoresis, Microfluidics, Others
Component	Sensors, Reagents, Software, Others
Application	Disease Diagnosis, Therapeutic Monitoring, Research Applications, Others
End User	Hospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings, Others
Functionality	Automated, Semi-automated, Manual, Others
Installation Type	Fixed, Mobile, Others
Equipment	Single-Use Devices, Reusable Devices, Others
Solutions	Point-of-Care Testing, Centralized Laboratory Testing, Others

The End User segment of the Advanced Blood Analysis Devices Market includes Hospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings, and Others. Hospitals held the largest share in 2025, owing to high testing volumes and the need for rapid blood analysis across emergency care, intensive care, surgery, and routine diagnostics. Home Care Settings are expected to be the fastest-growing segment during the forecast period, supported by the expansion of remote patient monitoring, decentralized testing, chronic disease management, and compact blood-analysis technologies. Diagnostic laboratories remain major users because of their testing capacity, while research institutes utilize advanced analyzers for biomedical and clinical research.

Geographical Overview

North America held the largest share of the Advanced Blood Analysis Devices Market in 2025, supported by advanced diagnostic infrastructure, high laboratory automation adoption, and strong demand for rapid and accurate blood testing. The U.S. remained the primary contributor, with hospitals, diagnostic laboratories, and emergency-care facilities increasingly adopting automated hematology analyzers, blood gas analyzers, and point-of-care testing systems. High diagnostic testing volumes, established healthcare networks, and the presence of leading medical-device manufacturers further strengthen regional demand. Increasing integration of artificial intelligence, automation, and digital laboratory connectivity is also supporting the adoption of advanced blood analysis technologies across clinical and research settings.

Asia Pacific is expected to be the fastest-growing region in the Advanced Blood Analysis Devices Market during the forecast period. Growth is being driven by expanding healthcare infrastructure, rising diagnostic testing volumes, increasing healthcare expenditure, and greater adoption of automated laboratory technologies. China and India are key contributors, while Japan and South Korea continue to support demand for sophisticated diagnostic systems. Growing screening programs for blood disorders, infectious diseases, and chronic conditions are creating additional opportunities for advanced analyzers. Increasing investments in private diagnostic laboratories, hospital modernization, point-of-care testing, and AI-enabled blood analysis are expected to further accelerate adoption across emerging and developed markets in the region.

Key Trends and Drivers

Increasing Adoption of Automated and Point-of-Care Blood Analysis:

A key trend in the advanced blood analysis devices market is the increasing adoption of automated, miniaturized, and point-of-care technologies that enable faster analysis of blood samples. Advanced devices are incorporating microfluidics, biosensors, automation, and digital connectivity to perform multiple tests with smaller sample volumes and reduced manual intervention. Point-of-care systems are particularly gaining importance because they can provide diagnostic information closer to patients in hospitals, clinics, emergency departments, and decentralized healthcare settings. Integration with digital health platforms and laboratory information systems is further improving data management, supporting a shift toward faster, more connected, and increasingly decentralized blood testing workflows.

Growing Need for Rapid and Accurate Blood-Based Diagnostics:

A key driver of the advanced blood analysis devices market is the growing need for rapid, accurate, and efficient blood-based diagnostic testing across healthcare settings. Blood analysis plays an important role in identifying and monitoring infections, metabolic disorders, cardiovascular conditions, hematological diseases, and other health conditions. Healthcare providers increasingly require technologies that can deliver reliable results quickly while handling growing testing volumes and minimizing manual processing. Rising demand for early disease detection, expansion of point-of-care testing, increasing chronic disease monitoring, and the need to improve laboratory efficiency are encouraging hospitals, diagnostic laboratories, and other healthcare providers to adopt advanced blood analysis devices.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS32833

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Technology
2.4 Key Market Highlights by Component
2.5 Key Market Highlights by Application
2.6 Key Market Highlights by End User
2.7 Key Market Highlights by Functionality
2.8 Key Market Highlights by Installation Type
2.9 Key Market Highlights by Equipment
2.10 Key Market Highlights by Solutions

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Benchtop Analyzers
- 4.1.2 Portable Analyzers
- 4.1.3 Handheld Analyzers
- 4.1.4 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Blood Gas Analyzers
- 4.2.2 Electrolyte Analyzers
- 4.2.3 Glucose Analyzers
- 4.2.4 Coagulation Analyzers
- 4.2.5 Hematology Analyzers
- 4.2.6 Immunoassay Analyzers
- 4.2.7 Others
4.3 Market Size & Forecast by Technology (2020-2035)
- 4.3.1 Spectroscopy
- 4.3.2 Flow Cytometry
- 4.3.3 Chromatography
- 4.3.4 Electrophoresis
- 4.3.5 Microfluidics
- 4.3.6 Others
4.4 Market Size & Forecast by Component (2020-2035)
- 4.4.1 Sensors
- 4.4.2 Reagents
- 4.4.3 Software
- 4.4.4 Others
4.5 Market Size & Forecast by Application (2020-2035)
- 4.5.1 Disease Diagnosis
- 4.5.2 Therapeutic Monitoring
- 4.5.3 Research Applications
- 4.5.4 Others
4.6 Market Size & Forecast by End User (2020-2035)
- 4.6.1 Hospitals
- 4.6.2 Diagnostic Laboratories
- 4.6.3 Research Institutes
- 4.6.4 Home Care Settings
- 4.6.5 Others
4.7 Market Size & Forecast by Functionality (2020-2035)
- 4.7.1 Automated
- 4.7.2 Semi-automated
- 4.7.3 Manual
- 4.7.4 Others
4.8 Market Size & Forecast by Installation Type (2020-2035)
- 4.8.1 Fixed
- 4.8.2 Mobile
- 4.8.3 Others
4.9 Market Size & Forecast by Equipment (2020-2035)
- 4.9.1 Single-Use Devices
- 4.9.2 Reusable Devices
- 4.9.3 Others
4.10 Market Size & Forecast by Solutions (2020-2035)
- 4.10.1 Point-of-Care Testing
- 4.10.2 Centralized Laboratory Testing
- 4.10.3 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Technology
  - 5.2.1.4 Component
  - 5.2.1.5 Application
  - 5.2.1.6 End User
  - 5.2.1.7 Functionality
  - 5.2.1.8 Installation Type
  - 5.2.1.9 Equipment
  - 5.2.1.10 Solutions
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Technology
  - 5.2.2.4 Component
  - 5.2.2.5 Application
  - 5.2.2.6 End User
  - 5.2.2.7 Functionality
  - 5.2.2.8 Installation Type
  - 5.2.2.9 Equipment
  - 5.2.2.10 Solutions
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Technology
  - 5.2.3.4 Component
  - 5.2.3.5 Application
  - 5.2.3.6 End User
  - 5.2.3.7 Functionality
  - 5.2.3.8 Installation Type
  - 5.2.3.9 Equipment
  - 5.2.3.10 Solutions
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Technology
  - 5.3.1.4 Component
  - 5.3.1.5 Application
  - 5.3.1.6 End User
  - 5.3.1.7 Functionality
  - 5.3.1.8 Installation Type
  - 5.3.1.9 Equipment
  - 5.3.1.10 Solutions
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Technology
  - 5.3.2.4 Component
  - 5.3.2.5 Application
  - 5.3.2.6 End User
  - 5.3.2.7 Functionality
  - 5.3.2.8 Installation Type
  - 5.3.2.9 Equipment
  - 5.3.2.10 Solutions
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Technology
  - 5.3.3.4 Component
  - 5.3.3.5 Application
  - 5.3.3.6 End User
  - 5.3.3.7 Functionality
  - 5.3.3.8 Installation Type
  - 5.3.3.9 Equipment
  - 5.3.3.10 Solutions
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Technology
  - 5.4.1.4 Component
  - 5.4.1.5 Application
  - 5.4.1.6 End User
  - 5.4.1.7 Functionality
  - 5.4.1.8 Installation Type
  - 5.4.1.9 Equipment
  - 5.4.1.10 Solutions
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Technology
  - 5.4.2.4 Component
  - 5.4.2.5 Application
  - 5.4.2.6 End User
  - 5.4.2.7 Functionality
  - 5.4.2.8 Installation Type
  - 5.4.2.9 Equipment
  - 5.4.2.10 Solutions
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Technology
  - 5.4.3.4 Component
  - 5.4.3.5 Application
  - 5.4.3.6 End User
  - 5.4.3.7 Functionality
  - 5.4.3.8 Installation Type
  - 5.4.3.9 Equipment
  - 5.4.3.10 Solutions
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Technology
  - 5.4.4.4 Component
  - 5.4.4.5 Application
  - 5.4.4.6 End User
  - 5.4.4.7 Functionality
  - 5.4.4.8 Installation Type
  - 5.4.4.9 Equipment
  - 5.4.4.10 Solutions
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Technology
  - 5.4.5.4 Component
  - 5.4.5.5 Application
  - 5.4.5.6 End User
  - 5.4.5.7 Functionality
  - 5.4.5.8 Installation Type
  - 5.4.5.9 Equipment
  - 5.4.5.10 Solutions
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Technology
  - 5.4.6.4 Component
  - 5.4.6.5 Application
  - 5.4.6.6 End User
  - 5.4.6.7 Functionality
  - 5.4.6.8 Installation Type
  - 5.4.6.9 Equipment
  - 5.4.6.10 Solutions
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Technology
  - 5.4.7.4 Component
  - 5.4.7.5 Application
  - 5.4.7.6 End User
  - 5.4.7.7 Functionality
  - 5.4.7.8 Installation Type
  - 5.4.7.9 Equipment
  - 5.4.7.10 Solutions
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Technology
  - 5.5.1.4 Component
  - 5.5.1.5 Application
  - 5.5.1.6 End User
  - 5.5.1.7 Functionality
  - 5.5.1.8 Installation Type
  - 5.5.1.9 Equipment
  - 5.5.1.10 Solutions
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Technology
  - 5.5.2.4 Component
  - 5.5.2.5 Application
  - 5.5.2.6 End User
  - 5.5.2.7 Functionality
  - 5.5.2.8 Installation Type
  - 5.5.2.9 Equipment
  - 5.5.2.10 Solutions
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Technology
  - 5.5.3.4 Component
  - 5.5.3.5 Application
  - 5.5.3.6 End User
  - 5.5.3.7 Functionality
  - 5.5.3.8 Installation Type
  - 5.5.3.9 Equipment
  - 5.5.3.10 Solutions
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Technology
  - 5.5.4.4 Component
  - 5.5.4.5 Application
  - 5.5.4.6 End User
  - 5.5.4.7 Functionality
  - 5.5.4.8 Installation Type
  - 5.5.4.9 Equipment
  - 5.5.4.10 Solutions
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Technology
  - 5.5.5.4 Component
  - 5.5.5.5 Application
  - 5.5.5.6 End User
  - 5.5.5.7 Functionality
  - 5.5.5.8 Installation Type
  - 5.5.5.9 Equipment
  - 5.5.5.10 Solutions
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Technology
  - 5.5.6.4 Component
  - 5.5.6.5 Application
  - 5.5.6.6 End User
  - 5.5.6.7 Functionality
  - 5.5.6.8 Installation Type
  - 5.5.6.9 Equipment
  - 5.5.6.10 Solutions
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Technology
  - 5.6.1.4 Component
  - 5.6.1.5 Application
  - 5.6.1.6 End User
  - 5.6.1.7 Functionality
  - 5.6.1.8 Installation Type
  - 5.6.1.9 Equipment
  - 5.6.1.10 Solutions
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Technology
  - 5.6.2.4 Component
  - 5.6.2.5 Application
  - 5.6.2.6 End User
  - 5.6.2.7 Functionality
  - 5.6.2.8 Installation Type
  - 5.6.2.9 Equipment
  - 5.6.2.10 Solutions
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Technology
  - 5.6.3.4 Component
  - 5.6.3.5 Application
  - 5.6.3.6 End User
  - 5.6.3.7 Functionality
  - 5.6.3.8 Installation Type
  - 5.6.3.9 Equipment
  - 5.6.3.10 Solutions
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Technology
  - 5.6.4.4 Component
  - 5.6.4.5 Application
  - 5.6.4.6 End User
  - 5.6.4.7 Functionality
  - 5.6.4.8 Installation Type
  - 5.6.4.9 Equipment
  - 5.6.4.10 Solutions
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Technology
  - 5.6.5.4 Component
  - 5.6.5.5 Application
  - 5.6.5.6 End User
  - 5.6.5.7 Functionality
  - 5.6.5.8 Installation Type
  - 5.6.5.9 Equipment
  - 5.6.5.10 Solutions

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Abbott Laboratories
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Roche Diagnostics
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Siemens Healthineers
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Beckman Coulter
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Sysmex Corporation
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Horiba
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Bio-Rad Laboratories
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Instrumentation Laboratory
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Nova Biomedical
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Radiometer Medical
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Mindray Medical International
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Thermo Fisher Scientific
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Becton Dickinson
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 PerkinElmer
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 HemoCue
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 Alere
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Ortho Clinical Diagnostics
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Randox Laboratories
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 EKF Diagnostics
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 Meril Life Sciences
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us